Careers  |   Log In  |   Register  |   Welcome Center  |   Follow Us  Facebook  Twitter Google Plus

Latest in Business of Medicine

According to Reuters, Sanofi SA has just launched an inhalable insulin medication in an effort to boost its diminishing drug sales in the face of competition from Eli Lilly and Novo Nordisk. Afrezza, the only inhalable form of insulin, should act faster...
According to Reuters, Abiomed Inc. stocks have gone up by 30 percent in extended hours trading after the company received FDA approval for its new heart pump device and raised revenue forecasts for the year ending March 31 by more than $10 million. The...
US based pharmaceutical company Pfizer plans on reducing the price of Prevnar 13, its pneumococcal vaccine, by 6 percent down to $3.10 in poor countries, Reuters reports. This comes as part of the company’s commitment to the GAVI global vaccines...